Transmedics Group Inc (TMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 160,764 | 143,823 | 157,370 | 143,537 | 121,624 |
| Cost of Goods | 67,350 | 59,248 | 60,781 | 55,309 | 49,611 |
| Gross Profit | 93,414 | 84,575 | 96,589 | 88,228 | 72,013 |
| Operating Expenses | 72,491 | 61,523 | 60,803 | 61,094 | 63,980 |
| Operating Income | 21,273 | 23,300 | 36,567 | 27,443 | 8,644 |
| Interest Expense | 3,354 | 3,491 | 3,476 | 3,461 | 3,571 |
| Other Income | 3,714 | 3,222 | 3,091 | 2,694 | 1,916 |
| Pre-tax Income | 21,633 | 23,031 | 36,182 | 26,676 | 6,989 |
| Income Tax | -83,750 | -1,288 | 1,275 | 994 | 132 |
| Net Income Continuous | 105,383 | 24,319 | 34,907 | 25,682 | 6,857 |
| Net Income | $105,383 | $24,319 | $34,907 | $25,682 | $6,857 |
| EPS Basic Total Ops | 3.10 | 0.71 | 1.03 | 0.76 | 0.20 |
| EPS Basic Continuous Ops | 3.09 | 0.71 | 1.03 | 0.76 | 0.20 |
| EPS Diluted Total Ops | 2.59 | 0.66 | 0.92 | 0.70 | 0.19 |
| EPS Diluted Continuous Ops | 2.59 | 0.60 | 0.86 | 0.64 | 0.19 |
| EPS Diluted Before Non-Recurring Items | 0.57 | 0.66 | 0.92 | 0.70 | 0.19 |
| EBITDA(a) | $28,741 | $30,149 | $43,298 | $33,580 | $14,324 |